Back to Search
Start Over
Depressive symptom deterioration among predominantly Hispanic diabetes patients in safety net care.
- Source :
-
Psychosomatics [Psychosomatics] 2012 Jul-Aug; Vol. 53 (4), pp. 347-55. Date of Electronic Publication: 2012 Mar 27. - Publication Year :
- 2012
-
Abstract
- Objective: This study examines clinical predictors of symptom deterioration (relapse/recurrence) at the completion of a clinical intervention trial of depressed, low-income, predominantly Hispanic diabetes patients who were randomized to socio-culturally adapted collaborative depression treatment or usual care and who no longer met clinically significant depression criteria at 12 months post-trial baseline.<br />Methods: A sub-cohort of 193 diabetes patients with major depression symptoms at baseline, who were randomized to a 12-month collaborative care intervention (INT) (problem-solving therapy and/or pharmacotherapy, telephone symptom monitoring/relapse prevention, behavioral activation and patient navigation support) or enhanced usual care (EUC), and who did not meet major depression criteria at 12 months were subsequently observed over 18 to 24 months.<br />Results: Post-trial depression symptom deterioration was similar between INT (35.2%) and EUC (35.3%) groups. Among the combined groups, significant predictors of symptom deterioration were baseline history of previous depression and/or dysthymia (odds ratio [OR] = 2.66), 12-month PHQ-9 score (OR = 1.22), antidepressant treatment receipt during the initial 12-months (OR = 2.38), 12-month diabetes symptoms (OR = 2.27), and new ICD-9 medical diagnoses in the initial 12 months (OR = 1.11) (R2 = 27%; max-rescaled R2 = 37%; likelihood ratio test, χ2 = 59.79, df = 5, P < 0.0001).<br />Conclusions: Among predominantly Hispanic diabetes patients in community safety net primary care clinics whose depression had improved over 1 year, more than one-third experienced symptom deterioration over the following year. A primary care management depression care protocol that includes ongoing depression symptom monitoring, antidepressant adherence, and diabetes and co-morbid illness monitoring plus depression medication adjustment and behavioral activation may reduce and/or effectively treat depression symptom deterioration.<br /> (Copyright © 2012 The Academy of Psychosomatic Medicine. All rights reserved.)
- Subjects :
- Antidepressive Agents therapeutic use
Comorbidity
Cooperative Behavior
Depression ethnology
Depression therapy
Depressive Disorder, Major ethnology
Depressive Disorder, Major therapy
Diabetes Mellitus, Type 2 ethnology
Female
Hispanic or Latino statistics & numerical data
Humans
Logistic Models
Los Angeles epidemiology
Male
Middle Aged
Patient Compliance
Problem Solving
Psychiatric Status Rating Scales
Psychotherapy, Group
Quality of Life
Recurrence
Self Care
Severity of Illness Index
Treatment Outcome
Community Health Services organization & administration
Depression psychology
Depressive Disorder, Major psychology
Diabetes Mellitus, Type 2 therapy
Health Status
Hispanic or Latino psychology
Subjects
Details
- Language :
- English
- ISSN :
- 1545-7206
- Volume :
- 53
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Psychosomatics
- Publication Type :
- Academic Journal
- Accession number :
- 22458987
- Full Text :
- https://doi.org/10.1016/j.psym.2011.12.009